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osting by EAbstract Introduction: The trigeminal neuralgia (TN) which is resistant to medical treatment
has been beneﬁted from many surgical techniques. Opinions differ regarding the best surgical
treatment.
Objective: This study was done to evaluate the functional results of percutaneous radiofre-
quency thermocoagulation of trigeminal nerve in a consecutive series of 312 patients suffering
from TN and to compare these results with the results of the other authors reported in the lit-
erature.
Methods: This retrospective study included 312 patients (280 with idiopathic TN, 8 with sec-
ondary or symptomatic TN, 20 with atypical TN, and 4 with post herpetic neuralgia) who
underwent radiofrequency thermocoagulation of trigeminal nerve. This study was done in
Alexandria main university hospital over a period of 7 years starting from January 2003 to
December 2009. The male to female ratio was 2 to 3 (124 males and 188 females) and their ages
ranged from 27 to 100 years with mean age of 48 years. All patients had preoperative MRI
brain examination. All cases underwent surgery in the form of radiofrequency thermocoagula-
tion (RFT) of the affected division or divisions of trigeminal nerve under intravenous short act-
ing anesthesia using C-arm radiological guidance. The straight temperature monitoring electrode
was used to perform an initial lesion at 60–70 C for 120 s and the patient awakened for sensory
testing, the lesion may be repeated at the same temperature and duration if sensory deﬁcit was
not evident. Also forty two patients with recurrence (30 with idiopathic TN, 3 with secondary
TN, and 8 with atypical TN, 1 with post herpetic neuralgia) had received anotheril.com
ersity Faculty of Medicine.
. All rights reserved.
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80 W. Fouadradiofrequency thermocoagulation lesion. Mean postoperative follow up examination period was
36 months.
Results: There was no operative mortality. Postoperatively, all the patients had immediate pain
relief but only 86.5% of cases (270 patients) had continuous pain relief (250 with idiopathic TN,
5 with secondary or symptomatic TN, 12 with atypical TN, 3 with post herpetic neuralgia).
After a mean postoperative follow up examination period of 1 year pain recurred in forty
two patients (13.5%) (30 with idiopathic TN, 3 with secondary TN, and 8 with atypical TN,
1 with post herpetic neuralgia). The operation was repeated in all cases with recurrence but only
30 cases were improved and the rest were shifted to other treatment modalities. Excellent results
were obtained in 64% of patients, good results in 25.5% of patients, fair results in 6.5% of
patients, and poor results in 4% of patients.
Conclusion: TN was predominant in females and the majority of patients had right V3 distri-
bution. The outcome depends on the type of TN with best results with classical idiopathic type.
Also better results occurred with isolated V3 affection. The radiofrequency thermocoagulation
of trigeminal nerve is a low risk, highly effective and minimally invasive procedure that should
be started with in all cases of TN.
ª 2011 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V.
All rights reserved.1. Introduction
Trigeminal neuralgia (TN) is a neuropathic pain involving one
or more of trigeminal nerve divisions. It is classiﬁed into four
types according to etiology which are idiopathic, secondary,
atypical and post herpetic.1 Also it is classiﬁed into two types
according to clinical characteristics of pain which are classical
TN (CTN) and mixed TN (MTN).2
Idiopathic TN (ITN) is paroxysmal shock like electrical
pain restricted to one or more of trigeminal divisions. It is
the most common form of TN.3,4 TN (TN) can also be sec-
ondary to a structural pathology such as tumors, vascular
malformation, or it can be the result of multiple sclerosis.3,5
Atypical TN may be idiopathic or secondary and is charac-
terized by constant facial pain combined with the more typ-
ical episodic pain of ITN. Post herpetic TN is a
complication of herpes zoster viral infection characterized
by burning pain at the trigeminal branch involved.6 The
classical type is characterized by a unilateral, episodic, elec-
tric shock like pain and it includes all cases of idiopathic
etiology and some cases of secondary causes. The mixed
type characterized by constant dull, burning pain between
paroxysms and includes all cases of atypical TN, post
herpetic neuralgia and some cases of secondary TN.7
The treatment of TN which is resistant to medical treat-
ment has beneﬁted from many surgical techniques.8 Opin-
ions differ regarding the best surgical treatment. Some
favor the microvascular decompression (MVD) of the
trigeminal nerve or partial trigeminal rhizotomy whereas
others prefer percutaneous procedures like glycerol rhizoly-
sis, radiofrequency thermocoagulation (RFT), and balloon
compression that injure the trigeminal nerve, the Gasserian
ganglion or retrogasserian rootless so that peripheral stimuli
no longer trigger an attack of TN.9,10 These procedures have
little mortality and morbidity and require little or no general
anesthesia.11 They are therefore useful for the elderly pa-
tients, those who do not wish to undergo major intracranial
operation. Also they are less time consuming and less costly
treatments.11,121.1. Aim of the work
This study was done to evaluate the functional results of per-
cutaneous radiofrequency thermocoagulation (RFT) of tri-
geminal nerve in a consecutive series of 312 patients
suffering from TN and to compare these results with the
results of the other authors reported in the literature.2. Methods
This retrospective study included 312 patients who underwent
radiofrequency thermocoagulation of trigeminal nerve for
treatment of TN. These patients were subdivided according
to their etiology into four types (280 with idiopathic TN, 8
with secondary or symptomatic TN, 20 with atypical TN,
and 4 with post herpetic TN). Also they were subdivided
according to clinical characteristics of pain into two groups
(282 with CTN, 30 with MTN). This study was done in
Alexandria main university hospital over a period of 7 years
starting from January 2003 to December 2009. The male to
female ratio was 2 to 3 (124 males and 188 females) and their
ages ranged from 27 to 100 years with mean age of 48 years.
Characteristics of 312 patients with TN who underwent
radiofrequency thermocoagulation are given in Table 1.
All patients had preoperative MRI brain examination to
diagnose the cases of secondary TN. All the patients had been
treated with anticonvulsants and all had taken colanzepam (up
to 6 mg per day) and/or carbamazepine (up to 1200 mg per
day) for a period of at least 6 months and most patients had
never had complete pain relief with drugs (85%), the others
(15%) could not tolerate the drugs. Ten patients with ITN
had previous failed microvascular decompression operation
of trigeminal nerve (MVD).
All cases underwent surgery in the form of radiofre-
quency thermocoagulation of the affected division or divi-
sions of trigeminal nerve under intravenous short acting
anesthesia using C-arm radiological guidance. The site of
needle puncture is at the end of nasolabial fold
Table 1 Characteristics of 312 patients with TN who underwent RFT.
0Etiology No. of cases Sex Side Division of trigeminal nerve aﬀected
M F Right Left Bilateral V1 V2 V3 V1,V2 V2,V3 V1,V2,V3
Idiopathic TN 280 109 171 147 132 1 7 48 129 2 88 6
Secondary TN 8 4 4 3 5 2 3 3
Atypical TN 20 9 11 11 8 1 1 3 3 3 4 6
Post-herpetic TN 4 2 2 3 1 2 2
Total 312 124 188 164 146 2 8 53 137 5 97 12
Figure 2 Facial hyperemia in the distribution of right V2 during
RFT.
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engagement of the needle in the foramen ovale, the stellate
is removed and we checked for the free ﬂow of CSF from
the needle that means that the needle in the retrogasserian
rootlets rather than the ganglion itself.
Under C-arm control lateral view we checked the optimal
position of the needle which is petroclival junction and 5 mm
anterior to plane of the clivus in V3, at the clivus in V2, and
5 mm posterior to plane of the clivus in V1 (Fig. 1). Also the
use of electrophysiological stimulation to check the optimal
site of the needle was done. The generator of radiofrequency
used was RFG-3C from Radionics. The appreciation of elec-
tric like sensations in the trigger area by low voltage stimula-
tion of 0, 1–0, 3 V at 50–75 Hz, for 3 ms duration was a
good sign that the electrode was in a good position. The ideal
location of electrode was achieved by gently moving the elec-
trode in or out a few millimeters. If the patient had previously
been treated and had some residual sensory deﬁcit more than
0.5 V is required. The impedance in the CSF retrogasserian
rootlets was between 120 and 350 ohm.
The straight temperature monitoring electrode was used to
perform an initial lesion at 60 C for 120 s and the patient is
awakened for sensory testing, the lesion may be repeated at
the same temperature and duration if sensory deﬁcit was not
evident. In cases with MTN the temperature was higher
(65–70 C) and the time of the lesion was between 4 and
6 min. A ﬂush was usually noted in the face, usually in the area
where the lesion is being made (Fig. 2). Loss of corneal reﬂex
could be prevented the eyelash blink reﬂex during the lesion-
ing. Also the lesion was repeated in forty two patients with
recurrence (30 with idiopathic TN, 3 with secondary TN, 8
with atypical TN, one with post herpetic neuralgia).
Postoperative follow up examination period ranged from
1.5 to 5 years with a mean of 3 years.Figure 1 Radiographic control for placement of the needle in forame
division. (B) The needle at the plane of clivus in V2 division. (C) The3. Results
3.1. Technical success
RFT was technically successful (completed) in all cases. If the
patients could not localize or quantify the lesion during the
procedure, it could be successfully completed on the basis of
observation of facial hyperemia in the affected distribution
of the trigeminal nerve, electrophysiological monitoring and/
or radiological guidance. The overall initial success of the pro-
cedure depends on two factors, completion of the procedure
and initial pain relief.
3.2. Postoperative morbidity and mortality
There was no operative mortality. Dysesthesia was deﬁned as a
disturbing sensation in the face that required medicaln ovale. (A) The needle 5 mm anterior to the plane of clivus in V3
needle 5 mm posterior to the plane of clivus in V1 division.
Table 2 Results after the ﬁrst percutaneous RFT.
Etiology No. of cases Excellent results Good results Fair results Poor results
No. % No. % No. % No. %
Idiopathic TN 280 190 68 55 19.5 5 2 30 10.5
Secondary TN 8 1 12.5 3 37.5 1 12.5 3 37.5
Atypical TN 20 10 50 2 10 8 40
Post-herpetic TN 4 1 25 2 50 1 25
Total 312 192 61.5 70 22.5 8 2.5 42 13.5
82 W. Fouadtreatment and it occurred in 36% of cases. It was minor dyses-
thesia in 28% of cases and major in only 8% of cases. Anesthe-
sia dolorosa was deﬁned as a constant burning dysesthesia in
the face that did not respond to medical treatment. It did
not occur in any case of this study. Mild facial numbness oc-
curred in almost all cases and it was well tolerated by most pa-
tients, it usually disappears after one month. Temporary
corneal anesthesia occurred in three cases with V1 trigeminal
pain. Trigeminal motor dysfunction is usually temporary and
subsides in the ﬁrst 3 months, but it was permanent in ﬁve
cases. Meningitis occurred in one case that responded well to
medical treatment.
3.3. Postoperative pain relief
Scores using visual analog pain scale (VAS) were reported by
the patients before and after the operation.
3.4. Initial pain relief
All the patients had immediate pain relief. Follow up of the pa-
tients was done at one month, three months, and thereafter
each 6 months. The evaluations include pain relief, facial sen-
sitivity deﬁcit, hypoesthesia, neurological deﬁcit, clinical com-
plications and pain recurrence. The patients were classiﬁed
into four groups according to their results. Group 1: excellent
results: pain relief, analgesia, tactile sensitivity deﬁcit at the tri-
geminal branch affected with no neurological complication.
Group 2: good results: pain relief, analgesia, tactile sensitivity
deﬁcit at the trigeminal branch affected, with transient neuro-
logical complication (e.g. dysesthesia, masticatory muscles
paresis), Group 3: Fair results: pain relief with neurological
complication, unpleasant dysesthesia, permanent masticatory
paralysis or corneal ulcers or keratitis. Group 4: poor results:
partial or no improvement of pain. After the ﬁrst lesion
61.5% had excellent results, 22.5% had good results, 2.5%
had fair results and 13.5% had poor results Table 2.
3.5. Pain recurrence
The pain recurrence was deﬁned as pain recurring in the same
distribution of the initial trigeminal pain or in the trigeminal
division adjacent to the initial pain. Forty two patients
(13.5%) experienced pain recurrence (30 cases with idiopathic
TN, 3 with secondary TN, 8 with atypical TN, 1 patient with
post herpetic neuralgia). The highest rate of pain recurrence
was among cases of mixed TN 40% of cases. The pain
recurrence usually occurred within the ﬁrst year of follow up
period. Mean period of recurrence was 6 months. Another
radiofrequency lesion of the trigeminal nerve was done in all42 cases with recurrence. 30 patients improved (8 excellent re-
sults, 10 good results, 12 fair results). The correlation between
the recurrence of TN, the etiology and topography are given in
Table 3. After the second radiofrequency lesion, 64% had
excellent results, 25.7% had good results, 6.4% had fair re-
sults, 3.9% had poor results (Table 4).
Excellent or good results were more common in males
81.5% (101 males out of 124) compared to females which were
found in 52.5% (99 females out of 188). Also better excellent
or good results were found in single V3 distribution 91%
(125 out of 137 patients). Recurrence was most common in
cases with V1 distribution that constitutes 50% of cases (4
out of 8). The overall results of 312 cases according to type
(pain characteristics) and cause of TN are summarized in
Table 5 (Fig. 3).
4. Discussion
TN is the most frequent disorder to affect the ﬁfth cranial
nerve. It is relatively uncommon with an estimated incidence
four cases per 100,000 persons. The mean age of onset of
TN is around 50 years, but it is becoming not so unusual to
see cases of TN in younger patients especially mixed type of
TN.13
The pathogenesis of this pain in cases with CTN remains
doubtful despite extensive investigations. Many theories have
been provided to explain the possible mechanisms.14 The
peripheral theory supposed compression of the entry zone of
the trigeminal nerve by a vascular loop is conﬁrmed by many
authors and microvascular decompression had been proved to
be effective for treatment of TN.15,16 However it does not ex-
plain why trigger points in one division can cause pain in an-
other or why most trigger zones involve the anterior midline
face.16
The theory of a central mechanism of trigeminal pain in-
volves the dorsal root reﬂex.17 A tactile stimulus evokes a
repetitive self-exciting discharge. Neurophysiologic experi-
ments suggest that the nucleus caudalis modulates the transfer
of information through the rostral subnuclei of the spinal
trigeminal nuclei. These brain stem nuclei then act as gate
control system to mediate the sensation of trigeminal
pain.15,17 Also, anticonvulsant drugs depress excitatory trans-
mission in the spinal trigeminal tract and are used successfully
to treat TN in some patients. Although the central mechanism
undoubtedly affect the perception of pain there is no convinc-
ing evidence that it is the primary cause of TN. Lesions
involving the spinal trigeminal tract such as lateral medullary
infarct, tumor or syringobulbia have never been reported
to cause TN-like pain.18 Another working hypothesis of a
peripheral cause and central pathogenesis proposed that
Table 3 Pain recurrence in correlation with etiology and topography.
Etiology Topography Patients Recurrences
No. % No. %
Idiopathic TN V1ﬁ 7 2.3 4 57
V2ﬁ 48 15.4 8 16.5
V3ﬁ 129 41.3 9 7
V1 + V2ﬁ 2 0.7 1 50
V2 + V3ﬁ 88 28 7 8
V1 + V2 + V3ﬁ 6 2 1 33.3
Secondary TN V2ﬁ 2 0.6 0 0
V3ﬁ 3 1 1 33.3
V2 + V3ﬁ 3 1 2 66.6
Atypical TN V1ﬁ 1 0.3 0 0
V2ﬁ 3 1 1 33.3
V3ﬁ 3 1 1 33.3
V1 + V2ﬁ 3 1 1 33.3
V2 + v3ﬁ 4 1.2 2 50
V1 + V2 + V3ﬁ 6 2 3 50
Post herpetic TN V3ﬁ 2 0.6 1 50
V2 + V3ﬁ 2 0.6 0 0
Total 312 100 42 13.5
Management of trigeminal neuralgia by radiofrequency thermocoagulation 83chronic irritation of trigeminal root results in partial loss of
some large myelinated axons which reduces the normal inhib-
itory inﬂuence of these ﬁbers on the nucleus caudalis. The
‘‘gate’’ is open to a barrage of afferent impulses and is
consciously appreciated as a pain paroxysm. This does not
explain why the paroxysms of pain stop. The poorly under-
stood balance of excitation and inhibition is probably
involved.14,19
But in cases with MTN the underlying mechanisms of the
disease remain unknown. Some authors hypothesized that
different facial pain syndromes represented sequential stages
of the same disease process, but other believed that central
sensitization or descending inhibition deﬁcits in the patients
is the cause of MTN.20 In this study, the persistent pain of 1
patient disappeared after the procedure but his ‘‘paroxysmal’’
pain remained. This patient was satisﬁed with the results of the
operation because the ‘‘paroxysmal’’ pain could be controlled
by medication. With another two patients, the paroxysmal
pain disappeared, but the persistent pain remained. They were
also satisﬁed with the operation results because their mild
persistent pain did not require medication. These patients
probably suffered from two different disorders as regards
the pathogenesis.
The characteristics of the patients in this series, such as
sex, affected side, and affected division, were consistent with
those of the previous reports.18,20,21 In this study patients
were predominantly female (male to female ratio was 2 to
3), pain was mainly right sided (right to left ratio was
1.12:1) and the mandibular area was most affected (44%).
The mean age of symptom onset was 48 years in the patients
with all types of TN. The mean age of symptom onset was
younger in the MTN group than in the CTN group (35.7
vs. 52 year). Bilateral symptoms were found in two of the pa-
tients, one with atypical TN and another with ITN. Further-
more, in this study 69% of the patients with MTN did not
respond well to medications, and 43.4% of them did not
respond to RFT very well.The main object of any treatment for TN is complete and
permanent relief of pain without any major disturbance of fa-
cial sensibility and without a major operation, which may car-
ry considerable risks of complications, particularly in the
elderly.22 Medical treatment is offered before surgical treat-
ment. Antiseizure medications (colanzepam or carbamazepine)
are the drugs of choice. They depress excitatory transmissions
in the nucleus caudalis. Unfortunately, up to 30% of patients
become refractory to it after 2 years.23 For patients who fail
medical therapy, a wide variety of surgical and percutaneous
procedures are available. Percutaneous retrogasserian thermo-
coagulation and microvascular decompression are the most
common surgical options. Thermocoagulation is fairly safe
and simple requiring only minimal anesthesia and hospitaliza-
tion. This technique of radiofrequency lesion was introduced
by Sweet and Wepsic in 1974.24 The method was designed to
produce trigeminal sensory loss, but only to pin prick not to
light touch. Controlled increment of radiofrequency currents
allows preferential destruction of ﬁbers that conduct pain (ﬁ-
nely myelinated A delta ﬁbers and unmyelinated C ﬁbers) with
some reservation of the heavily myelinated A beta ﬁbers which
conduct touch sensation.25 The procedure can be repeated.
Other percutaneous techniques including retrogasserian glyc-
erol rhizolysis and balloon compression have also been used
with good results. These are relatively simple and safe but have
higher recurrence rates and usually leave the patient with
extensive sensory loss.26 MVD is major neurosurgical proce-
dures that have a low recurrence rate and minimal sensory dis-
turbance but carry a risk of death and signiﬁcant morbidity.
This more aggressive surgical option may be best reserved
for younger patients who can tolerate the procedures and
beneﬁt most from the better long-term relief of pain or in
any patient who is a good surgical candidate and who strongly
wishes to avoid the risk of sensory loss.27
Postoperative pain relief depends on the technical success of
the procedure. A review of the more recent literature28–30
shows that thermocoagulation of the gasserian ganglion is
Table 4 Results after the second RFT and treatment of the non improved cases.
Etiology No. Topography Results Treatment of non improved cases
No. of improved cases No. of non improved cases and
their topography
Idiopathic TN 30 V1ﬁ 4 22 8 3e´ V1ﬁ supraorbital
neurectomy
V2ﬁ 8 V1ﬁ 3 2e´ V2ﬁ infraorbital nerve
block +MVD
V3ﬁ 9
V1,V2ﬁ 1 V2ﬁ 2
V2 + V3ﬁ 7 3e´
V2 + V3ﬁ RFT+ infraorbital
nerve block
V1,V2,V3ﬁ 1 V2 + V3ﬁ 3
Secondary TN 3 V2ﬁ 1 2 V2ﬁ 1 Radiosurgery
V2 + V3ﬁ 2
Atypical TN 8 V2ﬁ 1 5 3 1e´ V1 + V2ﬁ supraorbital
neurectomy + infraorbital nerve
block
V3ﬁ 1 V1 + V2ﬁ 1
V1 + V2ﬁ 1 2e´ V1,V2,V3ﬁ medical
treatment
V2 + V3ﬁ 2
V1,V2,V3ﬁ 3 V1 + V2 + V3ﬁ 2
Post herpetic TN 1 V3ﬁ 1 1
Total 42 30 12
Table 5 Overall results of 312 cases according to type (pain characteristics) and cause of TN.
Type of TN Etiology of TN No. of cases Excellent results Good results Fair results Poor results
No. % No. % No. % No. %
Classical TN Idiopathic TN 280 198 70.7 63 22.5 11 4 8 2.8
Secondary TN 2 1 50 1 50
Total 282 199 70.6 64 22.7 11 3.9 8 2.8
Mixed TN Secondary TN 6 4 66.6 1 16.7 1 16.7
Atypical TN 20 10 50 7 35 3 15
Post herpetic TN 4 1 25 2 50 1 25
Total 30 1 3.3 16 53.3 9 30 4 13.4
Total 312 200 64 80 25.7 20 6.4 12 3.9
84 W. Fouadactually performed with a technical success of 98–100%.
Immediate pain relief is reported as high as 90–95% in multi-
ple studies.28,30,31 More recent reports however, indicate that
long-term relief is enjoyed by as little as 58% of patients.18,30
In this series, 93.3% of the patients with CTN group re-
sponded to RFT as indicated by their self reported improve-
ment (VAS). Excellent results were obtained in 70.6% and
good results in 22.7% of the patients. These results were com-
parable to some recently reported ﬁndings.18,19 These data and
previous studies suggested that the success of RFT was similar
to those of MVD.7
In this series, only 56.6% of the patients in the MTN group
responded to RFT, with excellent outcomes achieved in only
3.3% of the patients and good outcomes in 53.3%. This sug-
gested that MTN might be an indication of RFT, which sup-
ports the notion put forward by Bennetto et al.,32 that RFT
can be used as a diagnostic procedure for atypical disease.The percutaneous radiofrequency thermo-coagulation had
a lower rate of pain recurrence compared with glycerol rhizot-
omy or balloon compression that is because retrogasserian le-
sion is controlled better with radiofrequency lesion, and the
thermal injury of the trigeminal rootlets is more effective than
chemical or mechanical injury.33 In this work the rate of pain
recurrence was 13.5% of the cases. Recurrence of pain as a re-
sult of revival of the nerve ﬁbers injured during the RFT was
found in both the CTN and MTN groups across a mean fol-
low-up period of up to 3 years. Overall, 30 patients (10.6%)
with CTN and 12 patients (40%) with MTN had a pain recur-
rence during the follow-up period. Among these, 8 patients in
the CTN group had recurrence within the ﬁrst year after the
procedure, and 9 in the MTN group did. After one year, the
relief of pain stabilized and the recurrence rate in the CTN
group was 7.8% (22/282) and the rate in the MTN group
was 10% (3/30), showing that the recurrence rates were
Figure 3 Results of RFT according to etiology of TN.
Management of trigeminal neuralgia by radiofrequency thermocoagulation 85comparable in the two groups. The longest follow up period in
this series lasted 5 years. A recent study, however, demon-
strated a recurrence rate of 7.6% over a follow-up period of
8.8 years. In this study, the rate of pain relief remained con-
stant after the second year in both the CTN group (97.2%)
and the MTN group (86, 6). This ﬁnding indicates that the
RFT is relatively reliable with respect to duration of pain
relief.
Broggi et al.34 reported the long-term results and prognostic
factors in 1000 patients with TN who underwent RFT after a
follow-up period ranged from 3 to 10 years. They reported that
76% of patients are completely pain-free without medication,
5% are pain free with a dosage of drugs lower than in the
pre-operative period and 15% require repeated surgery or high
dosage of drugs. The outcome in the multiple sclerosis group is
much worse, with only 39% of patients completely pain-free
without medication at long-term follow-up. Several prognostic
factors were tested (patient’s age and sex; involved side and
branch; duration of symptoms; history of previous trigeminal
ablative procedures; kind of neurovascular conﬂict; post-oper-
ative numbness; hypertension) and they observed that only
long duration of clinical history (>84 m) was found to be pre-
dictive of a worse outcome. In this study, none of these prog-
nostic factors was found to be predictive of a worse outcome.
However, they reported a considerable number of permanent
complications with nearly 10% with permanent masseter
weakness, corneal anesthesia in 20%. Six patients required sur-
gery for keratitis and 15 had a painful anesthesia and a further
52 required heavy medication for dysesthesia.34
Taha and Tew17 compared the results of 500 radiofre-
quency rhizotomies performed at the University of Cincinnati
with the results of large series reported in the literature20,21,35
including 6205 radiofrequency rhizotomies, 1217 glycerol
rhizotomies, 759 balloon compressions, 1417 MVD and 250
partial trigeminal rhizotomies. They concluded that radiofre-
quency rhizotomy is the procedure of choice for most patients
undergoing ﬁrst surgical treatment, unless the patient is a
healthy subject with isolated pain in the ﬁrst division and/or
he desires no sensory deﬁcit; in these cases MVD is recom-
mended. The results reported in their 500 radiofrequency rhiz-
otomies were the following: initial pain relief 98%, pain
recurrence (same distribution of the initial trigeminal pain or
in an adjacent trigeminal division) 20%, facial numbness
98%, minor dysesthesia 9%, major dysesthesia 2%, anesthesia
dolorosa 0.2%, corneal anesthesia 3%, keratitis 0.6%, trigem-
inal motor dysfunction 7%, perioperative morbidity 0.6%,
perioperative mortality 0%. Importantly, in their procedure
the goal was ‘‘dense hypoalgesia deﬁned as loss of two-thirds
or more of pinprick perception’’. After comparing their series
of radiofrequency rhizotomies with the results of large series ofpercutaneous procedures and with MVD, they reported a
success rate of 79% after balloon compression (mean follow
up 4 years), 80% following RFT procedures (mean follow-up
9 years), and 85% after MVD (mean follow-up 5 years).
Therefore the authors did not ﬁnd signiﬁcant differences in
the outcomes among the three therapeutic options.
The RFT caused no deaths in this study, but complications
developed in some cases, a total of 112 patients (36%) in both
groups experienced dysesthesia after the procedure, which was
gradually alleviated over time in some cases. 83 patients with
CTN (29.5%) reported dysesthesia of varying degrees in the
face, of them only 12 patients (4.3%) complained major dyses-
thesia. Twenty nine patients with MTN (96.6%) suffered from
dysesthesia, of themonly 13 patients (43.3%) complained ofma-
jor dysesthesia. Generally, the dysesthesia was mild and tolera-
ble. However, when the area of dysesthesia was larger than the
trigger area, patients tended to complain about the symptom,
especially when their pain could not be controlled effectively.36
Trigeminal motor dysfunction was permanent in ﬁve cases.
Meningitis occurred in one case that responded well to medical
treatment.
5. Conclusion
RFT under radiological guidance is a proven technique. It is
immediately effective for CTN and the rate of recurrence is
low. It is also effective withMTN, but different strategies should
be adopted inMTN treatment. If numbness and dysesthesia can
be conﬁned to the trigger area, patients will be greatly satisﬁed.
RFT is the procedure of choice for most patients undergoing
ﬁrst surgical treatment, it is a low risk, highly effective and min-
imally invasive procedure that should be started with in all cases
of TN, unless the patient is a healthy subjectwith isolated pain in
the ﬁrst division and/or he desires no sensory deﬁcit; in these
cases MVD is recommended.
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